Range of suitable people: CDEC talked over the uncertainty in the volume of people with reasonably critical to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Clinical specialists consulted by CADTH indicated that some individuals who will be categorised as acquiring gentle or moderate disease can have a intense bleeding ph… Read More